CervoMed CRVO
NASDAQ CRVO
$3.02 +0.09 (+3.07%)
At close: Oct 2, 2026 · 4:00 PM EDT

CervoMed (CRVO) Price to FCF (2023)

Updated

CervoMed's Price to FCF came in at 2.50 for Q2 2023, down 80.0% from the prior quarter.

Analysis

CervoMed (CRVO) Price to FCF (2023) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn
10 CervoMed 30.94 Mn 30.94 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2023 2.50
Mar 31, 2023 12.53
API Access

CervoMed Price to FCF API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=price-to-fcf&ticker=CRVO&period=max&api_key=YOUR_API_KEY